128 results on '"Poulton, Caroline J."'
Search Results
2. Lupus nephritis kidney biopsy characteristics and preterm birth.
3. Hemodialysis-Related Complement and Contact Pathway Activation and Cardiovascular Risk: A Narrative Review
4. Association of Lupus Nephritis Histopathologic Classification With Venous Thromboembolism—Modification by Age at Biopsy
5. Examining the role of patient-reported external factors and risk of relapse in anti-neutrophilic cytoplasmic autoantibody vasculitis.
6. ANCA autoantigen gene expression highlights neutrophil heterogeneity where expression in normal-density neutrophils correlates with ANCA-induced activation
7. Impact of Diabetic Lesions on Pathology, Treatment and Outcomes of Glomerular Diseases
8. Patient-Reported Outcome Instruments for Physical Symptoms Among Patients Receiving Maintenance Dialysis: A Systematic Review
9. Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis: a multi-center retrospective cohort study
10. ANCA Vasculitis Induction Management During the COVID-19 Pandemic
11. In-depth analysis of neurologic complications of ANCA vasculitis in a large inception cohort reveals novel associations: 18
12. Adverse events and infectious burden, microbes and temporal outline from immunosuppressive therapy in antineutrophil cytoplasmic antibody-associated vasculitis with native renal function
13. Rituximab as an immunosuppressant in antineutrophil cytoplasmic antibody-associated vasculitis
14. Podocyte-associated gene mutation screening in a heterogeneous cohort of patients with sporadic focal segmental glomerulosclerosis
15. Contraceptive Use and Elective Terminations in Women Enrolled in the Glomerular Disease Collaborative Network
16. Subfertility and early menopause in women with glomerular disease
17. Serum Albumin at Partial Remission Predicts Outcomes in Membranous Nephropathy
18. Intravenous pulse methylprednisolone for induction of remission in severe ANCA associated Vasculitis:a multi-center retrospective cohort study
19. Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
20. Measuring Circulating Complement Activation Products in Myeloperoxidase– and Proteinase 3–Antineutrophil Cytoplasmic Antibody–Associated Vasculitis
21. Understanding Long-term Remission Off Therapy in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis
22. Immunoglobulins G from patients with ANCA-associated vasculitis are atypically glycosylated in both the Fc and Fab regions and the relation to disease activity
23. CureGN Study Rationale, Design, and Methods: Establishing a Large Prospective Observational Study of Glomerular Disease
24. Predicting outcome in patients with anti-GBM glomerulonephritis
25. Predicting outcome in patients with anti-GBM glomerulonephritis
26. Proteinase-3 and myeloperoxidase serotype in relation to demographic factors and geographic distribution in anti-neutrophil cytoplasmic antibody-associated glomerulonephritis
27. Predicting Outcome in Patients with Anti-GBM Glomerulonephritis
28. Temporal and Demographic Trends in Glomerular Disease Epidemiology in the Southeastern United States, 1986–2015
29. Clinical Features and Outcomes of a Racially Diverse Population with Fibrillary Glomerulonephritis
30. Gene-Specific DNA Methylation Changes Predict Remission in Patients with ANCA-Associated Vasculitis
31. Examining the Role of External Factors with Risk of ANCA Vasculitis Relapse
32. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
33. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
34. Renal Survival in Patients with Collapsing Compared with Not Otherwise Specified FSGS
35. Trends in Long-Term Outcomes Among Patients With Antineutrophil Cytoplasmic Antibody-Associated Vasculitis With Renal Disease
36. Patients with primary membranous nephropathy are at high risk of cardiovascular events
37. Treatment with Glucocorticoids or Calcineurin Inhibitors in Primary FSGS
38. Pathways to renal biopsy and diagnosis among patients with ANCA small-vessel vasculitis
39. FP152INCREASE IN ADVERSE EVENTS WITH PULSED METHYLPREDNISOLONE USED FOR INDUCTION OF REMISSION IN SEVERE ANCA ASSOCIATED VASCULITIS
40. Gleaning relapse risk from B cell phenotype: decreased CD5+B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis
41. PTPN22 R620W Polymorphism and ANCA Disease Risk in White Populations: A Metaanalysis
42. Clinical characteristics and outcome of pauci-immune glomerulonephritis in African Americans
43. Personalized prophylactic anticoagulation decision analysis in patients with membranous nephropathy
44. Predictors of Treatment Outcomes in ANCA-Associated Vasculitis with Severe Kidney Failure
45. Decreased CD5+ B Cells in Active ANCA Vasculitis and Relapse after Rituximab
46. PTPN22 R620W Polymorphism and ANCA Disease Risk in White Populations: A Metaanalysis.
47. PTPN22R620W Polymorphism and ANCA Disease Risk in White Populations: A Metaanalysis
48. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.
49. Gleaning relapse risk from B cell phenotype: decreased CD5+ B cells portend a shorter time to relapse after B cell depletion in patients with ANCA-associated vasculitis.
50. Histone modification signature at myeloperoxidase and proteinase 3 in patients with anti-neutrophil cytoplasmic autoantibody-associated vasculitis
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.